Shares of Jaguar Health (JAGX) are currently trading higher in the pre-market, as we recently reported that the company revealed the sale of $6 million in Mytesi royalties to a secured lender last week.
A pharmaceuticals company focused on developing sustainable, novel gastrointestinal products, and Jaguar Health Inc is currently commercial-stage.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Before the market opened today, Jaguar Health’s (JAGX) share was trading at an increased price of $0.833, which was higher by 16.08%. The average volume for the stock during the last three-month period was 30.40 million. However, its shares are trading at a distance of 82.52% from its 20-days Simple Moving Average.